Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
03/2001
03/08/2001CA2383367A1 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
03/08/2001CA2348158A1 Modified adenoviral fibre and uses thereof
03/07/2001EP1080219A1 Amphotropic retrovirus packaging cell line, process for its production and use thereof
03/07/2001EP1080218A1 Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient
03/07/2001EP1080217A1 Recombinant cytomegalovirus expression system targeting the immediate-early gene region
03/07/2001EP1080216A2 Retroviral delivery system
03/07/2001EP1080215A1 Mutant herpes simplex viruses and uses thereof
03/07/2001EP1080200A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
03/07/2001EP1080199A2 (hemorrhagic enteritis) virus dna sequences, proteins encoded thereby and various uses thereof
03/07/2001EP1079868A1 Methods and apparatus for inactivating contaminants in biological fluid
03/07/2001EP1079864A1 Materials and methods for delivery and expression of heterologous dna in vertebrate cells
03/07/2001EP1079858A2 Oral immunization with papillomavirus virus-like particles
03/07/2001CN1286630A Targeted liposome gene delivery
03/07/2001CN1062770C Vaccine both for hepatitis A and measles, and production method therefor
03/06/2001US6197583 Therapeutic compounds
03/06/2001US6197568 Method and compositions for isolation, diagnosis and treatment of polyanion-binding microorganisms
03/06/2001US6197526 Polypeptides for binding human factor VIII and fragments of human factor VIII
03/06/2001US6197310 Causative agent of the mystery swine disease, vaccine compositions and diagnostics kits
03/06/2001CA2015315C Improved method of blood component decontamination by glucose addition and post-decontamination gassing
03/06/2001CA2007236C Process for preparing virus-free natural substances
03/01/2001WO2001014517A1 Method and apparatus for proliferating hepatitis virus
03/01/2001WO2001013941A1 Method for destroying, weakening and modifying micro-organisms, using high pressure
03/01/2001WO2000075365A3 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION
03/01/2001WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3)
03/01/2001WO2000061190A3 Treatment of intracellular infection
02/2001
02/28/2001EP1078105A1 Replication defective hiv vaccine
02/28/2001EP1078095A1 Viral production process
02/28/2001EP1078094A1 Methods and compositions for producing viral particles
02/28/2001EP1078051A2 Selection system
02/28/2001CN1062602C Gene of Chinese Strain herpes simplex virus thymidine knase, and application of same
02/27/2001US6194546 Influenza virus haemagglutinin which has a heterologous epitope at antigenic site a; vaccines against foot-and-mouth disease, poliovirus, human rhinovirus, hepatitis b virus, plasmodium and bacteria
02/27/2001US6194390 Administering hydroxyurea and a 2'-fluoropurine-dideoxy-nucleoside selected from the group of 2'-fluoro-2',3'-dide-oxyadenosine,-dideoxyinosine, and -dideoxyguanosine with a carrier or excipient; viricides; retroviruses; plant viruses
02/27/2001US6194210 Hepatitis A virus culture process
02/27/2001US6194192 Method of purifying and removing viruses
02/27/2001US6194191 Method for the production and purification of adenoviral vectors
02/27/2001US6193983 Equine herpesvirus glycoproteins
02/27/2001US6193981 Methods and compositions for impairing multiplication of HIV-1
02/27/2001US6193980 Replication defective herpes simplex virus comprising heterologous inserts
02/27/2001CA2025598C Chimaeric hepadnavirus core antigen proteins
02/22/2001WO2001012815A1 Coxsackie virus-derived vector system for gene transfer
02/22/2001WO2001012797A2 Method of separating rotavirus variants and live attenuated rotavirus vaccine
02/22/2001WO2001012793A1 Novel deoxyribonuclease, gene encoding the same and use thereof
02/22/2001WO2000071737A3 Improved retroviral production by inhibition of the enveloppe cell receptor
02/22/2001WO2000057904B1 Attenuated dengue-3 virus vaccine
02/22/2001DE19939095A1 Von Coxsackieviren abgeleitetes Vektorsystem für Gentransfer Of coxsackie-derived vector system for gene transfer
02/22/2001DE19937719A1 New nucleic acid from phage phiCh1, used to create vectors for expressing proteins and polymers in halophilic Archaea
02/22/2001CA2382090A1 Coxsackie virus-derived vector system for gene transfer
02/22/2001CA2379196A1 Rotavirus vaccine formulations
02/22/2001CA2346127A1 Novel deoxyribonuclease, gene encoding the same and use thereof
02/21/2001EP1076717A1 Recombinant baculovirus-based insecticides
02/21/2001EP0725825B1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
02/21/2001EP0652968B1 Defective adenoviruses
02/21/2001EP0580635B2 Modified plant viruses as vectors
02/21/2001CN1285000A Equine infections anaemia virus (EIAV) based
02/21/2001CN1284382A Attenuated pig genital and respiratory syndrome virus strain and its using method
02/20/2001US6190887 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein
02/20/2001US6190862 Identification, purification and detection of WSBV baculovirus associated with white spot syndrome
02/20/2001US6190861 Molecular sequences of swine retroviruses method of using
02/20/2001US6190859 Incubating sample with purified deactivated dengue virus having specific accession numbers, then detecting antibody-deactivated virus complex; safe diagnosis
02/20/2001US6190855 Systems and methods for removing viral agents from blood
02/20/2001US6190666 Can be used to transform animal cells for use in efficient production of desired products, such as proteins and vaccines
02/20/2001US6190609 High intensity light source; killing viruses in blood
02/20/2001US6190608 Exposure to emission type c ultraviolet radiation; free of nonenveloped viruses
02/15/2001WO2001011065A2 Hepatitis a virus clones adapted for growth in agmk cells
02/15/2001WO2001011045A1 A human lactoferrin produced by using an insect cell and method using the same
02/15/2001WO2001011034A2 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs
02/15/2001WO2000058482A3 Transducing phages
02/15/2001WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof
02/15/2001DE19936003A1 Lentivirus aus der Gruppe der Immunschwächeviren der Drillaffen(mandrillus leucophaeus) und ihre Verwendung Lentivirus from the group of immunodeficiency viruses of the drill monkey (mandrillus leucophaeus) and their use
02/15/2001CA2379166A1 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs
02/14/2001EP1075537A1 Bacteriophage assay
02/14/2001EP1075532A1 Partially deleted adenoviral vectors
02/14/2001EP1075529A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
02/14/2001EP1075524A2 Attenuated influenza viruses
02/13/2001US6188788 Automatic color saturation control in video decoder using recursive algorithm
02/13/2001US6187759 Canine parvovirus DNA vaccination
02/13/2001US6187572 Decontaminating blood and cell cultures by mixing with a chemical radiation sensitizer which does not bind to the membrane, freezing or freeze-drying the mixture, then exposing to electromagnetic radiation
02/13/2001US6187320 Which contain foreign dna elements in addition to the genome sequences necessary for the replication.
02/13/2001CA2180977C Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light
02/13/2001CA2160486C Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
02/08/2001WO2001009361A1 Recombinant hsv-1 and live viral vaccines
02/08/2001WO2001009309A2 RESCUE OF MUMPS VIRUS FROM cDNA
02/08/2001WO2001009305A2 Purine metabolism genes in plants
02/08/2001WO2001009291A1 Attenuated influenza virus useful as vaccine
02/08/2001WO2001009290A2 Avian infectious bronchitis virus serotype
02/08/2001WO2001009289A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses
02/08/2001WO2001009193A1 Chimeric polypeptides, method for production and uses thereof
02/08/2001WO2001009188A1 Binding moieties for fibrin
02/08/2001WO2001008703A1 Recombinant rsv virus expression systems and vaccines
02/08/2001WO2000076540A3 Streptococcus pneumoniae proteins and vaccines
02/08/2001WO2000066710A3 Method for the preservation of viruses and mycoplasma
02/08/2001WO2000061772A3 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
02/08/2001WO2000058487A3 Insect viral vectors and uses thereof
02/08/2001DE10019006A1 Neuartiger adenoviraler Vektor für den Gentransfer, seine Anwendung und seine Herstellung Novel adenoviral vector for gene transfer, its application and its preparation
02/08/2001CA2381056A1 Recombinant hsv-1 and live viral vaccines
02/08/2001CA2380799A1 Rescue of mumps virus from cdna
02/08/2001CA2380514A1 Attenuated influenza virus useful as vaccine
02/08/2001CA2380407A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses
02/08/2001CA2380108A1 Recombinant rsv virus expression systems and vaccines
02/08/2001CA2377064A1 Purine metabolism genes in plants